Platelet Rich Therapy for Facial Rejuvenation

NCT02730650 | Completed

• 1 other identifier: 15-00406
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

This study will be a prospective study of patients who undergo platelet-rich therapy (PRT) for facial rejuvenation at NYU Langone Medical Center. PRT has been increasingly used for wound healing, fat grafting, hemostasis as well as facial enhancement. PRT involves injection of patient's own platelets and fibrin, and has evolved as a less invasive technique for facial rejuvenation compared to more traditional techniques. Through the use of pre and post treatment photos, in addition to the FACE-Q Questionnaire and a clinician assessment, it is our hope that we will confirm the rejuvenating capabilities of PRT.

Conditions

Facial Rejuvenation

Keywords

FACE-Q; Platelet Rich Therapy; PRT

Outcome Measures

Primary Outcomes (1)

• Patient Satisfaction as measured by the FACE-Q scale

  1 Month Post-Surgery

Study Arms (1)

Platelet Rich Therapy

EXPERIMENTAL

Each subject will receive six injections of Platelet Rich Plasma (PRP) at designated points on each side of their face (twelve total). Injection points are spaced evenly across the inferior border of the cheek and mid-cheek, and are consistent on each patient. Patients will receive a post-injection phone call within 48 hours of the procedure. Photographs will be taken at two time points as part of the research to serve as a point of comparison before and after platelet rich plasma. Patients will receive the Global Aesthetic Improvement Scale amd tje Face-Q Questionnaire 1 month post-op

Other: Platelet Rich Therapy (PRT)

Interventions

Platelet Rich Therapy (PRT) OTHER

Platelet Rich Therapy (PRT) involves injection of patient's own platelets and fibrin.Topical anesthetic will be applied to the face for a period of fifteen minutes prior to the injection. For PRP preparation, 8 cc of blood will be collected from each patient just before each procedure. Approximately 0.3-0.4 cc of PRP will be injected into each standardized injection point in a superficial manner. The injections points are 6 points on each side of the face along the inferior border of cheek and mid-cheek (12 total). The PRP injection will be followed by 10-15 minutes of icing.

Platelet Rich Therapy

Eligibility Criteria

• Age: 21 Years - 80 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Males and females
• Ages 21 - 80
• Patients of all racial and ethnic origins
• Patients of Dr. Hazen undergoing facial rejuvenation

You may not qualify if:

• Patients undergoing facial rejuvenation using other methods including botox injections, chemical peels, face lifts and others.
• Patients using blood thinners that cannot be stopped
• Patients who have used aspirin within a week of the procedure date

Sponsors & Collaborators

• NYU Langone Health: lead

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

Location

Study Officials

• Alexes Hazen, MD

  NYU Langone Health

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 1, 2016
• First Posted: April 6, 2016
• Study Start: December 31, 2016
• Primary Completion: December 1, 2017
• Study Completion: December 28, 2017
• Last Updated: April 26, 2019

Record last verified: 2019-04

Locations

US (1)